1 ProteusONE and ProteusPLUS are brand names of 
Proteus 235 
acquisition of Radcal Corporation, an X-ray 
imaging specialist

The key figures in terms of 
financial results are as follows: Total 2023 Group revenues of EUR 428.7 
million, up 18.7% versus last year, in line 
with expectations and driven by accelerated 
backlog conversion in H2 across all 
business units, with particularly strong 
growth from Proton Therapy (PT) Services, Dosimetry and Other Accelerators